0001209191-15-066214.txt : 20150817 0001209191-15-066214.hdr.sgml : 20150817 20150817110420 ACCESSION NUMBER: 0001209191-15-066214 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150813 FILED AS OF DATE: 20150817 DATE AS OF CHANGE: 20150817 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JUNIPER PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000821995 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 592758596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4 LIBERTY SQUARE STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-639-1500 MAIL ADDRESS: STREET 1: 4 LIBERTY SQUARE STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: COLUMBIA LABORATORIES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MERRIFIELD C ANN CENTRAL INDEX KEY: 0001247224 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10352 FILM NUMBER: 151058119 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-08-13 0 0000821995 JUNIPER PHARMACEUTICALS INC JNP 0001247224 MERRIFIELD C ANN C/O JUNIPER PHARMACEUTICALS, INC. FOUR LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109 1 0 0 0 JNP Stock on Open Market 2015-08-13 4 P 0 1000 9.96 A 1000 D JNP Stock on Open Market 2015-08-14 4 P 0 2000 9.87 A 3000 D This transaction was executed in multiple trades at an average price of $9.96. The price reported above reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon further request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction were effected. This transaction was executed in multiple trades at an average price of $9.87. The price reported above reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon further request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction were effected. George O. Elston 2015-08-17